Palivizumab and emerging therapies for respiratory syncytial virus
- PMID: 22348302
- DOI: 10.1517/14712598.2012.665048
Palivizumab and emerging therapies for respiratory syncytial virus
Comment on
-
A review of palivizumab and emerging therapies for respiratory syncytial virus.Expert Opin Biol Ther. 2011 Nov;11(11):1455-67. doi: 10.1517/14712598.2011.608062. Epub 2011 Aug 11. Expert Opin Biol Ther. 2011. PMID: 21831008 Review.
Similar articles
-
A review of palivizumab and emerging therapies for respiratory syncytial virus.Expert Opin Biol Ther. 2011 Nov;11(11):1455-67. doi: 10.1517/14712598.2011.608062. Epub 2011 Aug 11. Expert Opin Biol Ther. 2011. PMID: 21831008 Review.
-
Respiratory syncytial virus: old challenges and new approaches.Pediatr Ann. 2005 Jan;34(1):62-8. doi: 10.3928/0090-4481-20050101-14. Pediatr Ann. 2005. PMID: 15693217 Review.
-
Early-life wheezing and respiratory syncytial virus prevention.N Engl J Med. 2013 May 9;368(19):1839-41. doi: 10.1056/NEJMe1302063. N Engl J Med. 2013. PMID: 23656652 Free PMC article. No abstract available.
-
Defining the burden of respiratory syncytial virus infection.J Pediatr (Rio J). 2013 Nov-Dec;89(6):517-9. doi: 10.1016/j.jped.2013.08.002. Epub 2013 Sep 19. J Pediatr (Rio J). 2013. PMID: 24055097 No abstract available.
-
Respiratory syncytial virus and recurrent wheeze.N Engl J Med. 2013 Aug 22;369(8):782. doi: 10.1056/NEJMc1307429. N Engl J Med. 2013. PMID: 23964948 No abstract available.
Cited by
-
Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.Antiviral Res. 2014 Apr;104:1-6. doi: 10.1016/j.antiviral.2014.01.008. Epub 2014 Jan 23. Antiviral Res. 2014. PMID: 24462695 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical